Dana Walker, MD, MSCE, is a seasoned medical professional with extensive experience in oncology. Currently serving as Vice President and Global Program Lead for Opdivo/Yervoy at Bristol Myers Squibb, Dana holds additional titles within the organization, including Vice President and Development Program Lead for GU malignancies, and Oncology Development Team Lead focusing on various cancer types such as head and neck, GBM, and breast cancers. Previously, Dana worked as an Associate Medical Director in Medical Safety Assessment at Bristol Myers Squibb and served as a Pediatric Oncologist at The Children's Hospital of Philadelphia, where Dana also completed a fellowship in Pediatric Hematology/Oncology and residency training.